These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11127422)

  • 1. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study.
    Sigmon SC; Steingard S; Badger GJ; Anthony SL; Higgins ST
    Exp Clin Psychopharmacol; 2000 Nov; 8(4):509-17. PubMed ID: 11127422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness.
    Sigmon SC; Higgins ST
    J Subst Abuse Treat; 2006 Jun; 30(4):291-5. PubMed ID: 16716843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingent reinforcement of abstinence with individuals abusing cocaine and marijuana.
    Budney AJ; Higgins ST; Delaney DD; Kent L; Bickel WK
    J Appl Behav Anal; 1991; 24(4):657-65. PubMed ID: 1797769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence.
    Peters EN; Hughes JR
    Drug Alcohol Depend; 2010 Jan; 106(2-3):111-8. PubMed ID: 19783385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study.
    Roll JM; Higgins ST; Steingard S; McGinley M
    Exp Clin Psychopharmacol; 1998 May; 6(2):157-61. PubMed ID: 9608347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.
    Rabin RA; Barr MS; Goodman MS; Herman Y; Zakzanis KK; Kish SJ; Kiang M; Remington G; George TP
    Neuropsychopharmacology; 2017 Oct; 42(11):2259-2271. PubMed ID: 28443616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; George TP
    Schizophr Res; 2018 Apr; 194():55-61. PubMed ID: 28285022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence.
    Budney AJ; Higgins ST; Radonovich KJ; Novy PL
    J Consult Clin Psychol; 2000 Dec; 68(6):1051-61. PubMed ID: 11142539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in aggressive behavior during withdrawal from long-term marijuana use.
    Kouri EM; Pope HG; Lukas SE
    Psychopharmacology (Berl); 1999 Apr; 143(3):302-8. PubMed ID: 10353434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marijuana abstinence effects in marijuana smokers maintained in their home environment.
    Budney AJ; Hughes JR; Moore BA; Novy PL
    Arch Gen Psychiatry; 2001 Oct; 58(10):917-24. PubMed ID: 11576029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users.
    Schuster RM; Hanly A; Gilman J; Budney A; Vandrey R; Evins AE
    Drug Alcohol Depend; 2016 Oct; 167():199-206. PubMed ID: 27590742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis Withdrawal in Adults With Attention-Deficit/Hyperactivity Disorder.
    Chauchard E; Hartwell KJ; McRae-Clark AL; Sherman BJ; Gorelick DA
    Prim Care Companion CNS Disord; 2018 Feb; 20(1):. PubMed ID: 29489073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craving in patients with schizophrenia and cannabis use disorders.
    Schnell T; Becker T; Thiel MC; Gouzoulis-Mayfrank E
    Can J Psychiatry; 2013 Nov; 58(11):646-9. PubMed ID: 24246436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
    Chauchard E; Septfons A; Chabrol H
    Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoactive Substance Use by Adults With Schizophrenia Before and During Cannabis Withdrawal.
    Koola MM; Kelly DL; McMahon RP; Boggs DL; Liu F; Gorelick DA
    Prim Care Companion CNS Disord; 2016 Sep; 18(5):. PubMed ID: 27835727
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms.
    Bechtold J; Hipwell A; Lewis DA; Loeber R; Pardini D
    Am J Psychiatry; 2016 Aug; 173(8):781-9. PubMed ID: 27138587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; Stefan C; Budney AJ; George TP
    Schizophr Res; 2018 Apr; 194():47-54. PubMed ID: 28506704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence.
    Rabin RA; Dermody SS; George TP
    Drug Alcohol Depend; 2018 Apr; 185():181-188. PubMed ID: 29459327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outpatient cannabis withdrawal programme].
    David F; Vandevivere T; Cortes-Lebon MA; Bernard V; Tisserand L; Danel T
    Soins Psychiatr; 2015; (296):37-40. PubMed ID: 25751912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of four treatments for marijuana dependence.
    Olmstead TA; Sindelar JL; Easton CJ; Carroll KM
    Addiction; 2007 Sep; 102(9):1443-53. PubMed ID: 17645430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.